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cutaneous secretions of amphibians have bioactive compounds, such as peptides, with potential 
for biotechnological applications. therefore, this study aimed to determine the primary structure 
and investigate peptides obtained from the cutaneous secretions of the amphibian, Leptodactylus 
vastus, as a source of bioactive molecules. the peptides obtained possessed the amino acid 
sequences, GVVDiLKGAAKDLAGH and GVVDiLKGAAKDLAGHLASKV, with monoisotopic masses 
of [M + H]± = 1563.8 Da and [M + H]± = 2062.4 Da, respectively. The molecules were characterized 
as peptides of the class of ocellatins and were named as Ocellatin-K1(1–16) and Ocellatin-K1(1–21). 
Functional analysis revealed that Ocellatin-K1(1–16) and Ocellatin-K1(1–21) showed weak antibacterial 
activity. However, treatment of mice with these ocellatins reduced the nitrite and malondialdehyde 
content. Moreover, superoxide dismutase enzymatic activity and glutathione concentration were 
increased in the hippocampus of mice. In addition, Ocellatin-K1(1–16) and Ocellatin-K1(1–21) were 
effective in impairing lipopolysaccharide (LPS)-induced reactive oxygen species (ROS) formation and 
nf-kB activation in living microglia. We incubated hippocampal neurons with microglial conditioned 
media treated with LPS and LPS in the presence of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) and 
observed that both peptides reduced the oxidative stress in hippocampal neurons. furthermore, these 
ocellatins demonstrated low cytotoxicity towards erythrocytes. these functional properties suggest 
possible to neuromodulatory therapeutic applications.
The skin of amphibians has been the subject of interest and study of several research groups as well as pharma-
ceutical industries, due to the abundance and diversity of bioactive molecules with potential biotechnological 
applications, especially for the production of new drugs1. The characteristic way of living of amphibians is divided 
between aquatic and the terrestrial environment2. They possess a highly sensitive skin that is essential to its res-
piration and is highly vulnerable to environmental aggressions, such as desiccation, attack of microorganisms, 
ultraviolet radiation, and injuries3. This vulnerability has culminated in the development of an innate defense 
system as a survival strategy based on the expression, production, accumulation, and secretion of bioactive 
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molecules, such as peptides, by glands located in the dermis of these animals4. Nevertheless, this vulnerability 
may reappear in the presence of a global biotic threat such as the chytridiomycosis that promoted a huge reduc-
tion of Amphibian biodiversity affecting many species of the Leptodactylidae family5.
Amphibian’s peptides are attractive candidates for investigating biological activities that may reveal detailed 
molecular defence mechanisms and high levels of functional diversity. They are known to function as antihy-
pertensives and vasodilators, opioids, peptidase inhibitors, neuropeptides, peptides for wound healing, nitric 
oxide inhibitors, insulin releasers, myotropics, antitumoral, antimicrobial, and antioxidant peptides6; all these 
properties affect potential predators and pathogens3. Although a number of such defense peptides have been 
reported against biological injuries, very few peptides against abiotic injuries, such as those caused by exposure 
to ultraviolet radiation have been studied.
In amphibians, exposure to ultraviolet radiation in the sensitive corneous area of the skin together with the 
difference in oxygen availability caused by the transition between the aquatic and terrestrial environment results 
in an accelerated endogenous production of reactive oxygen species (ROS)7. Under these conditions, when 
the environmental oxygen concentration is higher, the skin of the amphibians consumes more absorbed oxy-
gen instead of satisfying the oxygen demands of other tissues. In addition, loss of body water is associated with 
increased oxidative damage2. Thus, one may suggest that the skin of amphibians can contribute to homeosta-
sis against accelerated oxidative stress developed during changing environmental conditions for their survival. 
Among the strategies already known to protect amphibians from ultraviolet light are the proteins Melanopsin 
present in skin pigment cells8 and Pheomelanin found in the dorsal skin of Hymenochirus boettgeri9. Additionally, 
some studies have demonstrated antioxidant potential of peptides extracted from the cutaneous secretion of 
frogs, such as antioxidin-RL with a strong free radical scavenging ability2 and antioxidin-I that substantially 
attenuates the hypoxia-induced ROS production in living microglia, suggesting a potential neuroprotective role 
for this peptide10.
Oxidative stress is a cellular or physiological condition with a high concentration of ROS that causes molecu-
lar damage to cellular structures11. Although cells contain a number of antioxidant defenses for minimizing ROS 
fluctuations, situations where ROS generation often exceed the antioxidant capacity of cells are correlated with 
the onset and progression of many diseases through mutations of DNA, protein oxidation, and lipid peroxidation 
with consequent functional alterations and loss of vital functions in several tissues or organs12,13. In this context, 
considering that the neuroanatomic region of the brain is highly vulnerable to oxidative stress, molecules such as 
amphibian antioxidant peptides, which rapidly exert their biological functions by eliminating free radicals within 
several seconds may serve as promising neuroprotective agents.
Based on previously described data, the aim of this study is to identify and characterize Ocellatin-K1(1–16) 
and Ocellatin-K1(1–21) peptides isolated from cutaneous secretion of the tropical frog, Leptodactylus vastus, as a 
possible antioxidant agent in vivo and in vitro.
Results
isolation and structure characterization of new ocellatins. The identified and characterized ocel-
latins in this study were isolated from the amphibian, Leptodactylus vastus, which is found in an ecotonal region 
of the Brazilian northeast, undergoing great climatic variations, especially during periods of prolonged drought, 
often leading to mishaps during expeditions and dead individuals near temporary ponds (Fig. 1A–C). The 
chromatogram obtained from the cutaneous secretion of L. vastus presented diverse components absorbing at 
216 and 280 nm, suggesting that it contained several potential bioactive peptides (Fig. 1D). The peptide iden-
tification strategy of this work was outlined for Ocellatin class molecules. The mass spectrometry analysis per-
formed for chromatographic fractions eluted between 40–50 min revealed two ions with monoisotopic masses of 
[M + H]+ = 1563.9 and [M + H]+ = 2062.3 Da. De novo sequencing of these ions revealed the structures
GVVDI/LI/LK/QGAAK/QDI/LAGH (Fig. 2A) and GVVDI/LI/LK/QGAAK/QDI/LAGHI/LASK/QV 
(Fig. 2B), respectively. Additionally, the C-terminal of both peptides were not post-translated modified being 
R-COOH. I/L and K/Q ambiguities were resolved by Edman degradation and the primary structures were con-
firmed as GVVDILKGAAKDLAGH and GVVDILKGAAKDLAGHLASKV.
A search for similarities shows that both peptides reassembles structurally to ocellatins isolated from skin 
secretion of Leptodactylus frogs (Table 1)14–22. The alignment shows that both peptides have structural similarity 
to Ocellatin-K1 (UniProtKB/Swiss-Prot: P86711.1), comprised of 25 amino acid residues, and isolated from the 
cutaneous secretion of Amazonian toad-frog Leptodactylus knudseni. L. knudseni, L. fallax, L. pentadactylus and 
L. vastus comprise the groups of species named Leptodactylus pentadactylus23. As both deduced peptides char-
acterized here presented 16 (GVVDILKGAAKDLAGH) or 21 (GVVDILKGAAKDLAGHLASKV) amino acid 
residues identical to Ocellatin K1, and can be considered as truncated peptides of Ocellatin-K1, they were named 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21), respectively. In fact, an m/z corresponding to the Ocellatin-K1 was 
identified but its characterization was not possible because its low intensity signal presented in the mass spectrum 
(data not showed). Furthermore, the peptides studied in this work are also very closely related to Ocellatin-F, 
Ocellatin-L1 and Ocellatin-L2, both isolated from cutaneous secretions of amphibians from Central America.
The results of in silico analyses for molecular modeling and experimental data of circular dichroism show 
that these linear cationic peptides tend to possess an alpha-helix formation in the presence of TFE. In aqueous 
solution, they are randomized, but in TFE concentrations of 10 to 40%, the formation of secondary structures 
occurs (Fig. 3).
Antibacterial activity against strains of Escherichia coli and Staphylococcus aureus. To ana-
lyze the antibacterial activity of Ocellatin-K1(1–16) and Ocellatin-K1(1–21), we assayed the peptides against 
Gram-negative (Escherichia coli ATCC 25922) and Gram-positive (Staphylococcus aureus ATCC 25923) strains 
and MIC values were determined. The results obtained for both the ocellatins showed weak inhibitory activity 
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against E. coli with MIC of 125 μg/mL (Fig. 4) and inhibition percentage corresponding to 34.17 ± 11.66%. The 
optical density (630 nm) of E. coli decreased in a dose-dependent manner, showing significant reduction on via-
bility for both the ocellatins at concentrations between 125 and 1000 μg/mL. The value 125 μg/mL of MIC is too 
high to be characterized as having significant antibacterial potential. Moreover, only Ocellatin-K1(1–16) showed 
any significant activity against S. aureus featuring MICs of 31.25 μg/mL and inhibition percentage corresponding 
to 30.79 ± 10.27%. This activity was not seen to be concentration dependent. Ocellatin-K1(1–21) did not exert 
antibacterial activity against S. aureus at any of the tested concentrations (31.25 to 1000 μg/mL).
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on superoxide dismutase relative enzymatic  
activity. The results showed that SOD relative enzymatic activity in the hippocampal tissue homogen-
ate of animals treated with saline (control) alone was 396.3 ± 54.29 U SOD/µg protein. Acute treatment with 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21) at the tested doses (250 µg/kg) significantly (p < 0.05) stimulated 
SOD relative enzymatic activity (724.9 ± 88.90 U SOD/µg protein; and 616.0 ± 75.61 U SOD/µg protein, respec-
tively) compared to those treated with saline. Ascorbic acid (250 mg/kg), an antioxidant standard, demonstrated 
Figure 1. The largest delta in open seas in the Americas and the third largest in the world, the Rio Parnaiba 
Delta covers 70 islands within its 2,700 km2 area, that includes dunes, mangrove forest, and streams (A) 
(ArcMap v10.3, http://desktop.arcgis.com/en/arcmap/10.3). A temporary pond located in the city of Ilha 
Grande, State of Piaui. This habitat is home to L. vastus in this region (B). Adult male specimen of L. vastus 
(Photo: Jose Roberto S. A. Leite) (C). Reverse-phase HPLC chromatogram of the crude extract from L. vastus 
skin secretion. Fractions containing Ocellatin-K1(1–16) and Ocellatin-K1(1–21) are shown (D).
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basal levels of the endogenous antioxidant SOD (324.3 ± 66.61 U SOD/µg protein) compared to those of control 
as shown in Fig. 5A.
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on nitrite reduction.  Acute administra-
tion of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) significantly reduced (p < 0.05) the basal content of nitrite 
(0.0991 ± 0.0004 µM; and 0.1001 ± 0.0009 µM, respectively) compared to those observed in the saline group 
(0.1021 ± 0.0007 µM). This result suggests that treatment with ocellatins protects the hippocampus. Furthermore, 
ascorbic acid significantly reduced (p < 0.05) the nitrite content (0.0980 ± 0.0004 µM) compared with that of the 
control group (Fig. 5B). Thus, mice that were not treated with either ocellatins or ascorbic acid had higher con-
tents of nitrite.
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on glutathione concentration.  Acute 
administration of both Ocellatin-K1(1–16) and Ocellatin-K1(1–21), cellular defence agents, significantly elevated 
(p < 0.05) the GSH concentration (157.4 ± 6.71 µg/g tissue and 146.6 ± 7.62 µg/g tissue, respectively) compared 
to those with saline group (105.6 ± 18.68 µg/g tissue). Therefore, the protective effect of ocellatins administration 
might be explained by a resultant increase in the hippocampal GSH concentration. Administration of ascorbic 
acid (164.1 ± 15.60 µg/g tissue) also elevated hippocampal GSH concentration in the experimental group when 
compared to those in the saline group, as shown Fig. 5C.
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on malondialdehyde concentration.  Our 
results suggest that the administration of Ocellatin-K1(1–16) peptide maintained the basal concentration of 
MDA (163.0 ± 3.31 nmol/g tissue) and did not result in a significant difference in MDA concentration in the 
mice hippocampi when compared with those in saline group (169.5 ± 4.84 nmol/g tissue) as shown the Fig. 5D. 
However, Ocellatin-K1(1–21) peptide significantly (p < 0.05) reduced the redox state of the hippocampi of ani-
mals in the experimental group to 138.6 ± 6.61 nmol/g tissue when compared with animals treated with saline. 
Furthermore, the ascorbic acid (143.1 ± 8.53 nmol/g tissue) treatment also showed a significant (p < 0.05) effect 
compared to that of control group.
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on LPS-induced NF-kB activation in 
microglia. As demonstrated above, ocellatins decreased the basal ROS production and the oxidative state 
of the mice hippocampi. For a better understanding the role of the ocellatins redox regulation, we analysed the 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21) effect on lipopolysaccharide (LPS)-induced NF-kB activation in liv-
ing microglia using time-lapse video microscopy. To achieve this, we transfected the microglial cells with the 
Figure 2. MS/MS spectra for de novo sequencing of Ocellatin-K1(1–16), [M + H] ±  = 1563.9 Da (A) and 
Ocellatin-K1(1–21), [M + H]±  = 2062.3 Da (B) acquired using an MALDI-TOF/TOF UltraFlex Xtreme mass 
spectrometer.
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biosensor of NF-kB pathway inhibitor and observed that incubation with 100 μM of either Ocellatin-K1(1–16) 
or Ocellatin-K1(1–21) significantly (p < 0.01) prevented LPS-induced NF-kB activation in microglia when com-
pared with LPS only-treated group (Fig. 6) with no change in NF-kB basal activity.
Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on microglial-induced ROS formation in 
hippocampal neurons. The overactivated microglia released several molecules that could induce neuronal 
damage24. Since we observed that Ocellatin-K1(1–16) and Ocellatin-K1(1–21) blocked the LPS-induced activa-
tion of NF-kB by microglia, we hypothesized that ocellatins can protect hippocampal neurons from oxidative 
stress induced by microglial activation. Towards this objective, we treated hippocampal neurons with microglial 
conditioned medium, and observed a significant (p < 0.001) increase in ROS formation induced by the condi-
tioned media obtained from LPS-treated microglia in comparison with conditioned media from control micro-
glia (Fig. 7). We observed that both Ocellatin-K1(1–16) and Ocellatin-K1(1–21) significantly (p < 0.001) reduced 
neuronal oxidative stress elicited by LPS-treated microglia.
Name Sequence Mw¶(Da) pI µH Species
Ocellatin-K1 
(1–16) G V V D I L K G A A K D L A G H — — — — — — — — — — — — — — — — — 1563.82 6.75 0.483 L. vastus*
Ocellatin-K1 
(1–21) G V V D I L K G A A K D L A G H L A S K V — — — — — — — — — — — — 2062.44 8.51 0.399 L. vastus*




(fallaxin) G V V D I L K G A A K D I A G H L A S K V M N K L — — — — — — —
—




(laticeptin) G V V D I L K G A A K D L A G H L A T K V M N K L — — — — — — — — 2563.1 9.53 0.244 L. laticeps
Ocellatin-L2 G V V D I L K G A A K D L A G H L A T K V M D K L — — — — — — — — 2564 8.44 0.247 L. laticeps
Ocellatin-S 
(syphaxin) G V L D I L K G A A K D L A G H V A T K V I N K I — — — — — — —
—
a 2545 9.53 0.223 L. syphax
Ocellatin-V1 G V V D I L K G A G K D L L A H A L S K L S E K V — — — — — — — —a 2633.1 8.44 0.14 L. validus
Ocellatin-V2 G V L D I L K G A G K D L L A H A L S K I S E K V — — — — — — — —a 2576 8.44 0.274 L. validus
Ocellatin-V3 G V L D I L T G A G K D L L A H A L S K L S E K V — — — — — — — —a 2549 6.75 0.295 L. validus
Ocellatin-1 G V V D I L K G A G K D L L A H L V G K I S E K V — — — — — — — —a 2560 8.44 0.309 L. ocellatus
Ocellatin-2 G V L D I F K D A A K Q I L A H A A E Q I — — — — — — — — — — — —a 2379.7 6.75 0.269 L. ocellatus
Ocellatin-3 G V L D I L K N A A K N I L A H A A E Q I — — — — — — — — — — — —a 2202.5 6.75 0.438 L. ocellatus
Ocellatin-4 G L L D F V T G V G K D I F A Q L I K Q I — — — — — — — — — — — —a 2275.7 5.96 0.473 L. ocellatus
Ocellatin-5 G L L D F L K A A G K G L V T N L — — — — — — — — — — — — — — — —a 1730.0 8.59 0.489 L. ocellatus
Ocellatin-6 A V L D F I K A A G K G L V T N I M E K V G — — — — — — — — — — —a 2274.7 8.54 0.344 L. ocellatus
Ocellatin-P 
(penta-dactylin) G L L D T L K G A A K N V Vz G S L A S K V M E K L — — — — — — —
—
a 2543 9.53 0.324
L. penta-
dactylus
Ocellatin-PT1 G V F D I I K D A G K Q L V A H A M G K I A E K V — — — — — — — —a 2639.1 8.44 0.267 L. pustullatus
Ocellatin-PT2 G V F D I I K D A G K Q L V A H A T G K I A E K V — — — — — — — —a 260.9 8.44 0.272 L. pustullatus
Ocellatin-PT3 G V I D I I K G A G K D L I A H A I G K L A E K V — — — — — — — —a 253.0 8.44 0.271 L. pustullatus
Ocellatin-PT4 G V F D I I K G A G K Q L I A H A M G K I A E K V — — — — — — — —a 2595.1 9.53 0.252 L. pustullatus
Ocellatin-PT5 G V F D I I K D A G R Q L V A H A M G G K I A E K V — — — — — — —a 2667.1 8.5 0.268 L. pustullatus
Ocellatin-PT6 G V F D I I K G A G K Q L I A H A M E E K I A E K V G L N K D G N 3365.9 8.39 0.23 L. pustullatus
Ocellatin-PT7 G V F D I I K G A G K Q L I A H A M G G K I A E K V G L N K D G N 3293.8 9.4 0.212 L. pustullatus
Ocellatin-PT8 G V F D I K G A G K Q L I A R A M G K I A E K V G L N K D G N — 3312.9 9.82 0.214 L. pustullatus
Table 1. Sequence, Mw, pI, and hydrophobic moment of ocellatins class peptides isolated from Leptodactylus 
genus. ∞Underline letters represent conservative substitutions. aC -terminus amidated peptide. *Peptides this 
work.
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Haemolytic Assays of Ocellatin-K1(1–16) and Ocellatin-K1(1–21).  The haemolytic activities of ocel-
latins against human erythrocytes, as summarized in Fig. 8, indicate that Ocellatin-K1(1–16) peptide did not 
give rise to lysis at the concentrations tested (7.8 to 500 µg/mL), and there was no significant difference between 
the effects of ocellatins and the negative control (saline). However, the highest concentration (500 μg/mL) of 
the Ocellatin-K1(1–21) analysed, demonstrated approximately 35% haemolysis. Thus, these results suggest that 
Ocellatin-K1(1–16) is less toxic than Ocellatin-K1(1–21) in lysing erythrocytes.
Figure 3. Circular dichroism of peptides in aqueous solution and in 2,2,2-TFE. (A) Ocellatin-K1(1–16) and (B) 
Ocellatin-K1(1–21). (C) 3D structural model predictions of the ocellatins from Leptodactylus vastus (this study) 
compared to those of Ocellatin-K1 from Leptodactylus knudseni (Knudsen’s thin-toed frog).
Figure 4. Assessment of anti-microbial activity of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) by MIC assays 
against E. coli (A) and S. aureus (B) strains in a range of concentrations from 31.25 to 1000 μg/mL. The tests 
were performed in a single assay in triplicate. The results are expressed as mean ± SEM. *p < 0.05 vs. control 
group; **p < 0.01 vs. control group; ***p < 0.001 vs. control group; **** p < 0.0001 vs. control group. ANOVA 
and Sidak test. Abbreviations: K1(1–16): Ocellatin-K1(1–16); K1(1–21): Ocellatin-K1(1–21); OD: optical 
density.
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Effect of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on erythrocyte morphology and roughness.  
As demonstrated above, ocellatins showed low haemolytic activity in human erythrocytes. Thus, we analysed the 
human erythrocyte membrane morphology and roughness under AFM and the representative results are shown 
in Fig. 9. Untreated erythrocytes appeared as typical biconcave shape (Fig. 9A). After 30 minutes of incubation 
with Ocellatin-K1(1–16), no significant morphological changes in the cells were found at the concentrations 
tested (250, 500 and 1000 µg/mL; Fig. 9B–F, respectively). However, erythrocytes treated with Ocellatin-K1(1–16) 
peptide at a concentration 500 µg/mL demonstrated a significant increase of roughness (7.64 ± 0.56 nm) com-
pared to that observed in untreated samples (4.68 ± 0.22 nm), and this finding was statistically (p < 0.0001) sig-
nificant (Fig. 9H). In addition, it was observed that the biconcave topography of erythrocytes was altered by 
incubation with Ocellatin-K1(1–21) at a concentration 500 µg/mL for 30 minutes (Fig. 9E). Thus, characteristic 
protrusions indicating damage to the erythrocyte membrane were observed, which were not seen in control cells. 
Furthermore, exposure to Ocellatin-K1(1–21) at a concentration of 1000 µg/mL resulted in a significant change 
in the cell shapes (Fig. 9G) compared to that in control group. This damage could be confirmed by the signifi-
cant increase in the membrane roughness (11.44 ± 0.74 nm) of erythrocytes treated with Ocellatin-K1(1–21) at 
concentration of 1000 µg/mL, which was significantly increased (p < 0.0001) as compared to that in control cells.
Discussion
Amphibian’s skins are a rich resource of peptides, which have diverse biological activities and are regarded as 
potential sources of new therapeutic agents25. Studies have focused on the purification of novel antimicrobial 
peptides due to their considerable association with innate defence mechanisms26. In the current study, we ana-
lysed the antioxidant activity of two peptides purified from skin secretions of L. vastus. According to the sequence 
alignment of the structures obtained, the peptides were designated as Ocellatin-K1(1–16) and Ocellatin-K1(1–21) 
because they were leptodactylid peptides with similarities in amino acid sequence to the ocellatins. Many stud-
ies involving characterization of leptodactylid antimicrobial peptides have also been described18. However, 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21) showed weak antibacterial activity against the E. coli ATCC 25922 
and S. aureus ATCC 25923 strains tested. Previous reports indicate that not all ocellatins have antibacterial activ-
ity. Studies with Leptodactylus pustulatus22 revealed that Ocellatin-PT2 did not inhibit Gram-negative bacterial 
strains; however, Ocellatin-PT7 and -PT8 demonstrated antibacterial activities against a Gram-positive strain 
with low antimicrobial potency. In this study, other homologous ocellatins, such as ocellatin-PT1, -PT3, -PT4, 
Figure 5. Oxidative parameters in hippocampus of mice acutely treated with Ocellatin-K1(1–16) and 
Ocellatin-K1(1–21). (A) SOD relative enzymatic activity, (B) nitrite content, (C) GSH, and (D) MDA 
concentration. Ascorbic acid was used as a standard antioxidant. The results are expressed as mean ± SEM 
of a minimum of six animals per group. *p < 0.05 vs. saline group employing ANOVA and Newman–Keuls 
test. Abbreviations: AA: ascorbic acid; GSH: reduced glutathione; K1(1–16): Ocellatin-K1(1–16); K1(1–21): 
Ocellatin-K1(1–21); MDA: malondialdehyde; SAL: saline; SOD: superoxide dismutase.
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-PT5 and -PT6 inhibited one or more Gram-negative and -positive bacterial strains. These peptides differ by only 
a few amino acid substitutions and present different bactericidal activities. In our study, employing sequence 
alignments, Ocellatin-K1(1–16) and Ocellatin-K1(1–21) peptides showed sequence similarities with such ocel-
latins obtained from L. pustulatus. Thus, it may be suggested that small differences in sequences can lead to 
important differences in the activity spectra of the peptides. In addition, the antimicrobial activity of peptides is 
determined by a set of factors, such as conformation, net charge, hydrophobicity, and amphipathicity27. Further, 
despite Ocellatin-K1(1–16) and Ocellatin-K1(1–21) tend to adopt α-helices conformation at a hydrophobic envi-
ronment, a trait of amphibian’s antimicrobial peptide, they are truncated peptides of Ocellatin-K1 that possess 
the “additional” motif MNKL-NH2, when compared to Ocellatin-K1(1–21). The absence of the referred motif, 
as well as the lack of C-terminal amidation, may be promoting the reduced antimicrobial activities observed for 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21). C-terminal amidation is directly associated to an improvement in 
the abilities of cationic peptides to interact with biological membranes, a prerequisite to action of membrane 
active antimicrobial peptides28–30. Finally, the study of truncated peptides was reported for Hypsiboas raniceps 
and was associated to the loss of antimicrobial activity when compared to the intact molecule, probably reflecting 
distinct protective role between stored and secreted peptides31.
Considering that anura of L. vastus species live in the Parnaiba Delta Region, Northeast of Brazil, with expo-
sure to strong and long periods of sunlight radiation, wherein their skins are exposed to elevated ultraviolet 
radiation, they are likely to possess a specific and highly effective antioxidant system. Thus, the main objective of 
this study was to test if the new peptides isolated from cutaneous secretion of L. vastus have antioxidant activity. 
In vivo studies were performed using isolated hippocampus due to its high sensitivity to oxidative stress. Neural 
tissue has a high rate of oxygen consumption and possesses a high metabolic activity, and therefore, is a tissue 
more vulnerable to lipid peroxidation as compared to other tissues32. Consequently, antioxidant peptides, which 
rapidly exert their biological functions, have a potential to prevent neuronal damage related to lipid peroxidation. 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21) have small structures that help penetrate the blood–brain barrier 
(BBB) and exert antioxidant effects in the hippocampus. Indeed, some peptides cross the BBB through endocytic 
mechanisms involving receptor mediated transcytosis and/or adsorptive-mediated transcytosis. In recent years, 
BBB shuttle peptides have received growing attention because of their lower cost, reduced immunogenicity, bio-
logic specificity and higher chemical versatility33.
We demonstrated that Ocellatin-K1(1–16) and Ocellatin-K1(1–21) protected against oxidative stress at the 
concentrations tested. Our ocellatins were effective in increasing SOD activity and the basal concentration of 
GSH in hippocampal tissues. These markers protect cells against deleterious effects of free oxygen radicals, thus 
Figure 6. Ocellatin-K1(1–16) and Ocellatin-K1(1–21) prevented the LPS-induced NF-kB activation in living 
microglia. CHME3 human microglial cells expressing the biosensor of NF-kB pathway inhibitor were incubated 
with 100 μM Ocellatin-K1(1–16) or Ocellatin-K1(1–21) and challenged with 1 μg/mL LPS. Microglia were 
incubated only with Ocellatin-K1(1–16) and Ocellatin-K1(1–21) and compared with saline control group. 
Time-lapse fluorescence intensities for the NF-kB pathway inhibitor biosensor are shown (n = 17–19 cells 
pooled across two different experiments). The results are expressed as mean ± SEM. #p < 0.01 vs. LPS group; 
*p < 0.001 vs. CT not treated with LPS employing one-way ANOVA with Bonferroni post-test. Abbreviations: 
CT: control; LPS: lipopolysaccharide.
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providing a defence mechanism for the survival of aerobic organisms. SOD, a metalloenzyme, catalyses the 
dismutation of superoxide anions into oxygen and hydrogen peroxide. In addition, the tripeptide, GSH, pro-
tects cells against damage caused by reactive oxygen species, including free radicals and peroxides34. This study 
Figure 7. Ocellatin-K1(1–16) and Ocellatin-K1(1–21) protect hippocampal neurons from oxidative stress 
induced by LPS-treated-microglial conditioned media. Representative confocal images and quantification of 
ROS production in hippocampal neurons incubated with conditioned medium from microglia subjected to 
LPS-induced and 100 μM Ocellatin-K1(1–16) or Ocellatin-K1(1–21). Images show neurons expressing mVenus 
(green) and the Hyper Red ROS biosensor (red). The results are expressed as mean ± SEM calculated from 3 
different cultures. *p < 0.001 vs. LPS group; #p < 0.001 vs. CT employing one-way ANOVA with the Bonferroni 
post-test. Abbreviations: CT: control; LPS: lipopolysaccharide; MCM: microglia conditioned medium.
Figure 8. Haemolytic activity of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) in human erythrocytes at 
concentrations ranging from 7.8 to 500 µg/mL. A positive control was determined using a 10% solution of 
Triton X-100. ANOVA and t-test were used for statistical analysis.
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shows that the ocellatins decrease basal nitrite content, a nitric oxide metabolite, thus corroborating with the 
results cited above for SOD since this enzyme reduces nitrite levels by up to 50%35. Ocellatin-K1(1–16) only 
maintained basal concentration of MDA, a marker of oxidative stress and lipid peroxidation product; however, 
Figure 9. AFM representative images showing the morphology and roughness of human erythrocytes.  
(A) Morphology of untreated erythrocytes (control group) and after exposure to the Ocellatin-K1(1–16) (B,D,F 
at 250, 500, and 1000 µg/mL, respectively) and to the Ocellatin-K1(1–21) (C,E,G at 250, 500, and 1000 µg/mL, 
respectively). (H) Average roughness of human erythrocytes untreated (control) and treated with Ocellatin-K1(1–16) 
and Ocellatin-K1(1–21) at concentrations ranging from 250 to 1000 µg/mL. *p < 0.0001 vs. control group using 
ANOVA and t-test. Abbreviations: K1(1–16): Ocellatin-K1(1–16); K1(1–21): Ocellatin-K1(1–21).
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Ocellatin-K1(1–21) significantly reduced concentration of this aldehyde. In view of this observation, it may be 
suggested that Ocellatin-K1(1–21) has a greater protective effect by acting as a potential antioxidant than that 
of Ocellatin-K1(1–16). Thus, our findings suggest that exploring the antioxidant effects of the studied ocellatins 
could be of therapeutic interest in the context of pathologies associated with deficiencies in the enzymatic defence 
system against oxidative stress. The rapid antioxidant mechanism of peptides extracted from secretions from the 
skin of amphibians is unknown2. However, studies indicated that the presence of proline, methionine, cysteine, 
tyrosine, or tryptophan residues may contribute to the antioxidant function of peptides3. In contrast, it has been 
reported that peptides extracted from the secretion of amphibians containing the amino acid residues listed above 
did not necessarily demonstrate antioxidant activity36. Interestingly, the ocellatins studied here do not possess any 
of these amino acid residues.
As we previously described that ocellatins decrease ROS on mice hippocampi, we analysed the effect of 
Ocellatin-K1(1–16) and Ocellatin-K1(1–21) on LPS-induced NF-kB activation. Experimental studies show that 
stimulation by LPS induces microglial activation37. When microglia activated, they release several factors, such 
as ROS, and are capable of activate NF-kB transcription factor. NF-kB is a key transcription factor that plays an 
important role in the microglia activation by expressing iNOS, COX-2, and pro-inflammatory cytokines such 
as TNF-α, IL-1β, and IL-638. The activation of this transcription factor in microglia is widely associated with 
dysregulation of normal neuroinflammatory responses that characterizes neurodegenerative diseases39. In this 
study, we showed that Ocellatin-K1(1–16) and Ocellatin-K1(1–21) significantly prevented the LPS-induced 
NF-kB activation. Considering that the redox state controls NF-kB nuclear levels38, these results suggest that 
inhibition of NF-kB likely contributed to the antioxidant and anti-neuroinflammatory effects of the ocellatins in 
LPS-stimulated microglial cells. In microglial cells, antioxidants, such as ascorbate40 and piperlongumine41, also 
exert their effects by suppressing NF-kB activity.
Proinflammatory activation can induce microglia to release factors that damage neurons24. Thus, it is essential 
to control microglial reactivity in order to protect the neurons from excess ROS. Accordingly, we demonstrated 
that Ocellatin-K1(1–16) and Ocellatin-K1(1–21) reduced oxidative stress in hippocampal neurons incubated 
with LPS-treated microglia conditioned media. This suggests that these ocellatins can prevent microglial-induced 
neuronal toxicity.
The search for new molecules that have promising biological activities and do not cause harmful effects to 
humans is widely associated with trials investigating the possibility of natural products to injure plasma mem-
branes of human erythrocytes42. Therefore, an assay to estimate in vitro haemolytic capacity was performed as 
a toxin- screening method to estimate the potential of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) to cause cell 
damage that may be induced in vivo. Ocellatin-K1(1–16) did not cause haemolytic activity at the concentrations 
tested in this study, whereas Ocellatin-K1(1–21) demonstrated approximately 35% haemolysis at the highest 
concentration analysed. These results are consistent with results previously reported22, which demonstrated that 
others ocellatins isolated from the skin secretions of the frog, L. pustulatus, have low to none haemolytic activity. 
Thus, Ocellatin-K1(1–16) and Ocellatin-K1(1–21) showed considerable cellular biocompatibility towards mam-
malian cells in vitro.
Erythrocyte deformability was confirmed by AFM studies, which combines high-resolution imaging and 
functionality in a physiological environment43. Our morphological study on erythrocyte membrane surface indi-
cates that surface irregularities typical of normal erythrocytes were modified following high concentrations of 
exposure to Ocellatin-K1(1–16) and Ocellatin-K1(1–21). These results were quantitatively described by the mor-
phological roughness parameter of the erythrocyte outer leaflet membranes when comparing surface topographic 
features on a nanoscale level. These results showed that for both peptides, the concentration of 250 µg/mL, there 
was no significant change in cell morphology or membrane roughness. For both peptides, this concentration is 
above that tested in the oxidative stress assays (i.e. more than 100 µM). Only at higher concentrations (500 µg/mL 
and above), were significant changes seen in membrane texture or cell shape. The changes in the cell morphology 
of erythrocytes were broadly compatible with the haemolytic tests carried out in vitro. Thus, the observations 
associated with the functional properties of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) suggest possible thera-
peutic applications.
The results obtained in this study suggest that the Ocellatin-K1(1–16) and Ocellatin-K1(1–21) extracted from 
cutaneous secretions of the tropical frog, L. vastus, possess antioxidant activity in mice hippocampi by increasing 
SOD activity and GSH concentration, as well as by reducing nitrite content and MDA concentration. In addition, 
these ocellatins were effective in impairing LPS-induced NF-kB activation in living microglia cells and reducing 
oxidative stress elicited in hippocampal neurons incubated with conditioned media from LPS-treated microglia. 
These observations suggest that ocellatins can form the basis for discovery and development of novel agents that 
might control ROS production and microglial activation in order to treat or prevent oxidative stress associated to 
several neurological diseases.
Methods
isolation and characterization of the peptides. Adults frogs of Leptodactylus vastus (L. vastus) Lutz 
1930 (North-eastern Pepper Frog) species were manually captured in the Parnaiba Delta Region, Ilha Grande de 
Santa Isabel, Ilha Grande city, Piaui state, Brazil, under the license number, 61838–1 SISBIO/ICMBio (Fig. 1A–C). 
The cutaneous secretion from L. vastus was obtained by electrical stimulation (9 V), collected in 50 mL tubes con-
taining Milli-Q water, filtered (Millipore filters, 0.22 μm), immediate frozen, and lyophilized.
The lyophilized secretion of L. vastus (1 mg) was dissolved in Milli-Q water (500 μL) and subjected to 
reversed-phase chromatography (Shimadzu Co., LC-20 CE, Kyoyo, Japan), using a Vydac C18 reversed phase 
column (2018 TP). The fractions were eluted with a linear gradient of 0.1% (v/v) (trifluoroacetic acid) TFA/ace-
tonitrile ranging from 5% to 60% over 60 min and 75–95% over 5 min at a flow rate of 1 mL/min. Fractions were 
monitored at 216 and 280 nm, collected in tubes, and dried under centrifugation at low pressure.
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Chromatographic fractions were dissolved using Milli-Q water (in 100 to 500 µL) according to absorbance 
obtained. Each sample was mixed with α-cyano-4-hydroxyxinnamic acid (10 mg/mL dissolved in 50% acetoni-
trile/0.3% TFA (v/v) in Milli-Q water) in a proportion of 1:3 (v/v), spotted onto a MALDI plate and evapo-
rated at room temperature. The samples were analysed using an UltraFlex Xtreme mass spectrometer (Bruker 
Daltonics, Bilerica, MA) operating in the positive reflective mode. The mass range analysed was between m/z 800 
and 5000. Ions were selected for fragmentation using the LIFT™ mode. The mass spectrometer was controlled by 
FlexControl 4.0 software and MS/MS spectra were manually interpreted using FlexAnalysis 3.4 software. Before 
acquisition, the mass spectrometer was calibrated using peptide calibration Standard II solution. Further purifi-
cation steps enabled the confirmation of their amino acid sequences by Edman degradation.
peptide synthesis. Ocellatin-K1(1–16), sequence GVVDILKGAAKDLAGH-OH, and Ocellatin-K1 (1–21), 
sequence GVVDILKGAAKDLAGHLASKV-OH were manually synthesized by the 9-fluorenylmethyloxycarbonyl 
(Fmoc) solid-phase strategy starting with a Fmoc-His(Trt)-Wang resin (0.42 mmol/g) or with a Fmoc-Val-Wang 
resin (0.53 mmol/g) at 0.4 mmol scale. Couplings were performed with HBTU:DIPEA (O-(benzotriazol-
1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate:N-ethyl-N-propan-2-ylpropan-2-amine) in 
N,N-dimethylformamide (DMF) for 60–90 minutes. Fmoc deprotections were accomplished by a 25% 
4-methylpiperidine solution in DMF (2 × 15 min). The peptidyl-resin was washed with 2-propanol and DMF 
(4x each, alternating the solvents) after each coupling and deprotection step. Side chain deprotection and peptide 
cleavage step was carried out with 15 mL trifluoroacetic acid in the presence of 500 µL water and 500 µL triisopro-
pylsilane. Reagents used for peptide synthesis were acquired from Peptides International (Louisville, KY, USA). 
Purification was performed on a preparative reversed-phase column (Vydac 218 TP 510, Hesperia, CA) coupled 
to High Performance Liquid Chromatography (HPLC) system model LC-10VP (Shimadzu Corp., Kyoto City, 
Japan). The molecular weights and purity of samples were confirmed using MALDI-TOF/TOF mass spectrome-
try (Ultraflex, Bruker Daltonics, Bilerica, MA), as described elsewhere44.
Structural studies. Three-dimensional structural model predictions of the peptides were obtained using the 
internet resource, PEP-FOLD 3.5 (de novo peptide structure prediction). The secondary structures of the peptides 
were assessed by circular dichroism (CD) spectroscopy in the far ultraviolet spectrum, using a Jasco J-815 CD 
Spectropolarimeter (JASCO, Tokyo, Japan) as previously reported45. Briefly, the measurements were carried out 
under a nitrogen gas flow of 8 L/h at 20 °C. Spectra were obtained between 190 and 260 nm. The peptides were 
used at a concentration of 100 μM in Milli-Q water and at various concentrations in 2,2,2-trifluoroethanol (TFE). 
These experiments were performed at 37 °C and a scan speed of 50 nm/min; a response time of 1 s and a band-
width of 1 nm were used. The spectra were converted to molar ellipticity per residue as previously reported45,46.
Antibacterial activity. The bacterial strains Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 
25923, were used for the determination of antibacterial activity of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) 
peptides. The bacterial strains were grown at 37 °C in Mueller-Hinton broth until a logarithmic phase was reached 
[1–2 × 108 colony forming units (CFU)/mL]. Ocellatin-K1(1–16) and Ocellatin-K1(1–21) concentrations varying 
from 31.25 to 1000 μg/mL were prepared using serial dilutions. In each well, the final inoculum concentration 
was 5 × 105 CFU/mL. Minimum inhibitory concentration (MIC) was defined as the lowest peptide concentration 
that inhibited the visible bacterial growth for 24 h at 37 °C, in aerobic conditions. Besides the reading of visible 
bacterial growth, the optical density (630 nm) was evaluated for the calculation of the percentage of inhibition of 
bacterial growth where optical density of the untreated bacteria was considered 100% growth. The MIC determi-
nation was performed in triplicate and in a single experiment, according to the Clinical & Laboratory Standards 
Institute (CLSI) protocol47.
neurochemical studies in mice hippocampus for evaluation of antioxidant status. Animals. 
Male Swiss albino mice (Mus musculus), weighing 25–30 g, were maintained at a constant temperature of 
25 ± 1 °C. The mice were accommodated in opaque plastic polypropylene cages (maximum six animals per cage) 
under a standard environment of 12 h light/dark cycle and allowed free access to food and water. Procedures 
related to the care and use of animals in our experiments were performed in accordance to the Brazilian Society of 
Sciences of Laboratory Animals. The experiments were previously submitted to approval of the Ethics Committee 
on Animal Use (CEUA/UFPI) from Federal University of Piaui (protocol no. 001/2019). Euthanasia of animals 
were performed following the guidelines of the practice of euthanasia of CONCEA (National Council of the 
Control of Animal Experimentation), normative resolution no. 37 of February 15, 2018.
Experimental design. The animals were randomly allocated to four groups, and each group consisted of six ani-
mals. Animals in the first group were intraperitoneally (i.p.) treated with saline (vehicle) and served as negative 
control group. The second group received ascorbic acid, a standard antioxidant agent, at a dose of 250 mg/kg. 
The other two groups were treated with Ocellatin-K1(1–16) and Ocellatin-K1(1–21) at doses of 250 µg/kg. 
All the administrations were acute, by a single intraperitoneal injection on a single day, according to a previ-
ously described method35. After 1 h of each intraperitoneal administration, the mice were euthanized by an 
overdose of xylazine, N-(2,6-dimethylphenyl)-5,6-dihydro-4H-1,3-thiazin-2-amine (18 mg/kg) and ketamine, 
2-(2-chlorophenyl)-2-(methylamino)cyclohexan-1-one (240 mg/kg). Next, the brains were quickly removed and 
placed on ice. After dissection, each hippocampus was identified, weighed, and stored at -80 °C for subsequent 
preparation of homogenates and for biochemical analysis. The hippocampus tissues were used to determine 
superoxide dismutase (SOD) relative enzymatic activity and reduced glutathione (GSH) concentration, as well as 
nitrite content and malondialdehyde (MDA) formation.
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Determination of superoxide dismutase relative enzymatic activity. The SOD relative enzymatic activity were 
measured by the method described previously48. In this method, the enzyme activity is calculated by measuring 
the amount of SOD capable of inhibiting nitrite formation by 50%. Hippocampus tissues were homogenized in 
potassium phosphate buffer (50 mM, pH 7,4) to prepare 10% homogenates. Briefly, aliquots of 100 μL of each 
homogenate was added to 1.11 mL of phosphate buffer, 75 μL of L-methionine (20 mM), 40 μL of Triton X-100 
(1% v/v), 75 μL of hydroxylamine hydrochloride (10 mM), and 100 μL of EDTA (50 μM). Next, this mixture was 
heated in a boiling water bath at 37 °C for 5 min. Further, 80 μL of riboflavin solution (50 μM) were added and the 
mixture was exposed to light for 10 min. Later, 100 μL of this preparation together with 100 μL of Griess reagent 
were placed into wells, and the absorbance was measured at 550 nm after 10 min. In addition, the amount of total 
proteins was estimated using a protein assay kit (Labtest). The SOD relative enzymatic activity were expressed as 
unit enzyme activity per microgram of protein.
Determination of nitrite reduction. Reduction of nitrite was estimated based on the Griess reaction, according to 
the method described49. The hippocampus tissue samples were homogenized in 0.15 M KCl (1 mL/100 mg tissue), 
under cooling. Next, 100 μL of the supernatant were mixed with 100 μl of Griess reagent at room temperature for 
10 min. Absorbance was measured using a microplate reader at 540 nm. Nitrite concentration in the sample was 
determined using a sodium nitrite (NaNO2) standard curve. Results were expressed as micromoles.
Determination of reduced glutathione concentration. The content of reduced GSH of the hippocampus tissues, as 
a non-protein sulfhydryl, was estimated according to the method described50. Hippocampus tissues were homog-
enized in 0.02 M EDTA solution (1 mL/100 mg tissue). Aliquots (400 μl) of tissue homogenate were mixed with 
320 μL of distilled water and 80 μl of 50% (w/v) trichloroacetic acid in glass tubes and centrifuged at 3000 rpm 
for 15 min. Next, 400 μL of each supernatant was mixed with 800 μL of Tris buffer (0.4 M, pH 8.9) and 20 μL of 
0.01 M 5,5-dithio-bis (2-nitrobenzoic acid). After shaking the preparation, absorbance was measured at 412 nm 
by a spectrophotometer. GSH concentration was ascertained via a standard curve of reduced GSH, generated in 
parallel. The results were expressed as micrograms of GSH per gram of tissue.
Determination of malondialdehyde concentration. The levels of MDA in homogenates from each group were 
measured using the method described51, which is based on a thiobarbituric acid reaction. Hippocampus tissues 
were homogenized with 1.15% cold KCl to prepare 10% homogenates. In brief, 250 μL of each homogenate was 
added to 1.5 mL of 1% H3PO4 and 0.5 mL of 0.6% 2-methylpropan-2-ol (aqueous solution). Later, this mixture 
was stirred and heated in a boiling water bath for 45 min. The preparation was then cooled immediately in an ice 
water bath, followed by the addition of 2 mL of butan-1-ol. The mixture was shaken and the butan-1-ol layer was 
separated by centrifugation at 4000 rpm for 15 min. Optical density was determined at 535 and 520 nm, and the 
difference in optical density between the two estimates was calculated as the 2-methylpropan-2-ol value. MDA 
concentrations are expressed as nanomoles per gram of tissue.
RoS production in living microglia and neuronal cultures. Microglial cell line. The human micro-
glial cell line, CHME3, was obtained from primary cultures of human embryonic microglial cells by transfection 
with a plasmid encoding for the large T antigen of SV40. Such cells were previously used in microglial studies 
demonstrating similar activities related to primary cultures52. CHME3 microglia were cultivated as previously 
described40. In brief, cells were cultured in DMEM GlutaMAXTM-I, 100 U/mL penicillin, and 100 μg/mL strepto-
mycin supplemented with 10% FBS. Cells were kept at 37 °C, 95% air, and 5% CO2 in a humidified incubator. Cells 
were plated on plastic-bottom culture dishes (μ-Dish 35 mm, iBidi) for live imaging experiments.
Hippocampal neuronal cultures. Hippocampal neurons were obtained from E16 C56Bl/6 mice. After dissec-
tion in Ca2+- and Mg2+-free Hank’s Balanced Salt Solution (HBSS, Thermo Fisher Scientific, Waltham, MA), 
hippocampi were treated with trypsin (0.045% in HBSS) for 10 min at 37 °C (Thermo Fisher Scientific), washed 
with 10% fetal bovine serum in HBSS to block trypsin activity, and washed further in HBSS to remove serum and 
prevent the growth of glia. Finally, the hippocampi were transferred to serum-free Neurobasal medium (Thermo 
Fisher Scientific) supplemented with B27 (1:50, Thermo Fisher Scientific), glutamine (0.5 mM, Sigma-Aldrich, 
Merck), gentamicin (0.12 mg/mL, Thermo Fisher Scientific) and L-glutamate (25 µM, Sigma-Aldrich, Merck) and 
mechanically dissociated. Neurons were kept in supplemented Neurobasal medium on coverslips treated with 
nitric acid and coated with poly-D-lysine (20 µg/cm2, P0899, Sigma-Aldrich, Merck) at a density of 8 × 104 cells/
cm2, at 37 °C in a humidified incubator with 5% CO2/95% air for 7–8 days.
Transfection using the calcium phosphate co-precipitation method. Hippocampal neurons were transfected on 
the fifth day in vitro (DIV). Towards this end, 2 µg/coverslip of plasmid DNA (mVenus53 and HyPer Red ROS 
Biosensor54) were diluted in Tris-EDTA buffer (TE; 10 mM Tris, 1 mM EDTA), pH 7.3, and mixed with a cal-
cium chloride solution in HEPES (2.5 M CaCl2 in 10 mM HEPES), pH 7.2. This mixture of DNA/TE/Calcium 
was added to 2 x HEPES buffered saline (270 mM NaCl, 10 mM KCl, 1.4 mM Na2HPO4, 11 mM dextrose, and 
42 mM HEPES), pH 7.2. Precipitates were allowed to form for 30 min, with vortex mixing every 5 min, to ensure 
that the precipitates were of similar small sizes. Meanwhile, neurons were incubated with 2 mM kynurenic acid 
(4-oxo-1H-quinoline-2-carboxylic acid). The precipitate was then added to the neurons, and incubated at 37 °C, 
5% CO2/95% air, for 3 h. Neurons were then washed with acidic culture medium containing 2 mM kynurenic 
acid and incubated further for 15 min. Finally, the medium was replaced with the initial culture medium, and the 
neurons were further incubated in a 37 °C/5% CO2 incubator for 48 h to allow protein expression.
Microglia transfection was performed on the second DIV, using the same procedure as for neuronal trans-
fection, using 10 µg of DNA/plate (NFkB pathway inhibitor biosensors55 and the HyPer Red ROS Biosensor54) 
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with exception of the kynurenic acid incubation for live cell imaging. Assays were performed at least 48 h after 
transfection to allow protein expression.
Live cell imaging and quantification of biosensors. Experiments were performed on a fully-motorized DMI6000B 
microscope (Leica Microsystems) equipped with filter cubes for monomeric red fluorescent and far-red fluores-
cent protein mounted into a microscope filter carrousel (Leica fast filter wheels). The excitation light source was 
a mercury metal halide bulb integrated with an EL6000 light attenuator. Cells were observed with a PlanApo 
63 × 1.3NA glycerol immersion objective with a correction ring. An ORCA-Flash 4.0 V2 Digital CMOS camera 
(Hamamatsu) coupled to the microscope through a 1.3x c-mount adapter was used to acquire images. The LAS 
X software (Leica Microsystems) controlled all microscope parameters. At each time point, images were sequen-
tially acquired using 2 × 2 camera binning with an exposure time of 800 milliseconds. Time-lapse images were 
exported as 16-bit tiff files and processed by the FIJI software as described previously40,56,57. In brief, background 
was dynamically subtracted from time-lapses using the rollerball algorithm. Cells were individually segmented 
and thresholded using PFRET. Whole cell mean grey intensity values for each biosensor was retrieved and plotted.
Haemolytic assays. The haemolytic activity of Ocellatin-K1(1–16) and Ocellatin-K1(1–21) peptides was tested 
using human red blood cells (RBC) as previously described58, with some modifications. Briefly, RBCs were col-
lected in EDTA (1.8 mg/mL), washed three times with sterile saline solution (0.85%), and the pellets were resus-
pended and diluted in the same solution. The RBC suspension was added to an equal volume of each peptide 
solution at different concentrations (7.8–500 μg/mL). The mixtures were incubated for 30 minutes at 37 °C and 
then centrifuged at 8000 rpm for 1 min. The supernatants were removed and the value of absorbance (Abs) at 
492 nm was measured. Maximum haemolysis was determined by adding 0.1% Triton-X (v/v) to a sample of cells, 
and saline solution was used as negative haemolysis controls. The haemolysis percentage was calculated as fol-
lows: [(Abs peptide - Abs saline)/(Abs Triton - Abs saline)] × 100.
Atomic Force Microscopy (AFM) on the human red blood cells. Isolated human erythrocytes (control or treated) 
were fixed with 2% glutaraldehyde in 100 mM PBS, pH 7.4 for 2 hours while mixing, followed by deposition on 
poly-L-lysine coated coverslips and eventual washing with ultrapure water. The samples were air-dried overnight 
before imaging. AFM was performed with a JPK Nanowizard 4 instrument (JPK Instruments AG. Germany), in 
AC-AFM (tapping) mode, using ACT cantilevers with a resonant frequency of approximately 300 kHz.
Statistical analysis. All experimental data was expressed as mean ± standard error of the mean (SEM). Results 
from saline-treated control animals were used as baseline values. The results obtained from Ocellatin-K1(1–16) 
and Ocellatin-K1(1–21) or reference drug-treated test groups were compared with those obtained from 
saline-treated controls. All statistical analyses were performed with GraphPad Prism (version 6.0) software. The 
statistical significance of the differences between groups of experiments in vivo was determined by one-way anal-
ysis of variance (ANOVA) and the multiple comparison Student-Newman-Keuls test. The anti-microbial test 
was analysed using the ANOVA and Sidak test. The differences in the effects of compound treatment compared 
with control values to cell cultures were analysed by one-way ANOVA with the Bonferroni post-test. ANOVA and 
t-test were used to compare the measurements of haemolytic test. P < 0.05 was considered statistically significant.
Data availability
All data generated or analysed during this study are included in this article.
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